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Abstract
Background: Cytotoxic cells of the immune system have evolved a lysosomal compartment to store and mobilize
effector molecules. In T lymphocytes and NK cells, the death factor FasL is one of the characteristic marker proteins
of these so-called secretory lysosomes, which combine properties of conventional lysosomes and exocytotic
vesicles. Although these vesicles are crucial for immune effector function, their protein content in T cells has so far
not been investigated in detail.
Results: In the present study, intact membranous vesicles were enriched from homogenates of polyclonally
activated T cells and initially characterized by Western blotting and electron microscopic inspection. The vesicular
fraction that contained the marker proteins of secretory lysosomes was subsequently analyzed by 2D
electrophoresis and mass spectrometry. The proteome analysis and data evaluation revealed that 70% of the 397
annotated proteins had been associated with different lysosome-related organelles in previous proteome studies.
Conclusion: We provide the first comprehensive proteome map of T cell-derived secretory lysosomes with only
minor contaminations by cytosolic, nuclear or other proteins. This information will be useful to more precisely
address the activation-dependent maturation and the specific distribution of effector organelles and proteins in
individual T or NK cell populations in future studies.
Background
Cytotoxic T lymphocytes (CTL) and Natural Killer (NK)
cells are the main cytotoxic effector cells of the immune
system. In order to effectively eliminate virus-infected
and tumorigenic cells, they rapidly mobilize effector
molecules including granzymes, perforin, granulysin and
the death factor FasL (CD178) that are presumably
stored in preformed organelles termed secretory
lysosomes (SL) [1]. Secretory lysosomes combine
degradative properties of conventional lysosomes with
characteristics of exocytotic vesicles. At the level of
morphology, conventional and secretory lysosomes are
hardly distinguishable and both appear to represent end-
points of an endocytotic pathway and are formed by
fusion and fission of endosomes and lysosomes [2].
Similar to conventional lysosomes, large membrane areas
are covered by lysosome-associated membrane-proteins
(LAMPs) including LAMP-1 (CD107a), LAMP-2
(CD107b) and LAMP-3 (CD63) [3-5]. However, secretory
effector lysosomes are characterized by a specific set of
membrane and luminal marker proteins [6,7]. The cur-
rent consensus is that SL of CTLs and NK cells carry the
aforementioned effector proteins either in the lysosomal
lumen (granzymes, perforin and granulysin) or as charac-
teristic transmembrane compounds (FasL) [8-10].
Recently, we provided a protocol that allows a sub-
stantial enrichment of intact SL from in vitro expanded
lymphocyte populations [11]. Employing this procedure
for subcellular fractionation of a crude organelle pre-
paration, we obtained a fraction of intact vesicles that is
significantly enriched in SL marker proteins. We were
thus able to report the first comprehensive analysis of
the luminal proteome of secretory lysosomes from NK
cells [12]. At that time, 234 different proteins were
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associated with SL or other lysosomal compartments
before. Applying 2D difference gel electrophoresis, we
also described a cell line-specific distribution of func-
tionally relevant proteins in SL from human NK cell
lines and primary NK cells [12].
Based on this study, it appears likely that different
T cell populations utilize the SL organelles to store and
mobilize lineage-specific cargo proteins. However, the
proteome of secretory lysosomes in T cells has not been
deciphered. To provide the first proteome map for
T cell-derived SL, we enriched organelles from activated
T lymphoblasts. Organelle extracts were subjected to
SDS-PAGE and Western blotting to identify the FasL-
containing SL fraction. This fraction was analyzed by
electron microscopy to demonstrate the enrichment of a
homogeneous population of intact vesicles. In order to
define the luminal proteome of the respective SL com-
partment, the organelles were lysed and proteins were
separated by 2D gel electrophoresis. Mass spectrometry
was applied to identify individual spots. We annotated
397 proteins, 70% of which had been associated with
lysosome-related organelles before. With the present
report, we thus provide the first comprehensive descrip-
tion of the content of FasL-carrying effector vesicles iso-
lated from activated human T lymphocytes.
Results and Discussion
In our preceding analysis of the SL compartment of NK
cell lines and primary NK cells, we annotated 234 indi-
vidual proteins and demonstrated a cell line-specific dis-
tribution of several functionally relevant molecules
including cytotoxic effector proteins, lysosomal pro-
teases and MHC molecules [12]. As a basis to address
unsolved issues regarding the maturation, function and
cell type-specific composition of the cytotoxic effector
compartment in T cell populations, we now analyzed
the proteome of enriched secretory lysosomes from in
vitro activated human T cell blasts.
FasL-associated secretory lysosomes in activated
lymphocytes
We and others have shown that in CTLs, preformed
FasL accumulates in the limiting membrane of secretory
lysosomes with late endosome or multi-vesicular-body
structure and there co-localizes with characteristic lyso-
somal marker proteins including CD63 or lysosomal
hydrolases and cytoskeletal adapter proteins [7-9,13-15].
Confocal laser-scanning microscopy (CLSM) was applied
t oc o n f i r mt h a tF a s La l s om i g h ts e r v ea sam a r k e rf o r
secretory lysosomes in in vitro expanded PHA-stimu-
lated T lymphocytes used in the present study. As
depicted in Figure 1, we detected an apparent co-locali-
zation of CD63 with FasL, granzyme A and the
lysosomal protease cathepsin B. It should be mentioned
that a common or distinct localization of LAMP-3
(CD63) and FasL is still controversially discussed. Sev-
eral reports suggest a co-localization of FasL with gran-
ule proteins, such as cathepsin D, CD63, granzyme B,
perforin and LAMP-1 in a single granular entity [8,9]
whereas other studies indicate that CD63 and FasL are
located in distinct subcellular compartments [16].
Our protocol for the enrichment of secretory lyso-
somes yielded six separate fractions that were subjected
to further analysis by Western blotting or 2D gel elec-
trophoresis. To demonstrate an effective enrichment of
the SL fraction, we first separated the proteins of indivi-
dual fractions by SDS-PAGE and stained for characteris-
tic organelle marker proteins after Western blotting. As
shown in Figure 2, indicated by the high abundance of
FasL, CD63 and cathepsin D, SL were enriched in frac-
tion 2. Although LAMP-1 was also enriched in this frac-
tion, the presence of this lysosomal membrane protein
in other fractions might indicate the complex composi-
tion of the lysosomal compartment in general and that
other lysosome-related vesicles might exist with distinct
Figure 1 In T cell blasts, FasL associates with lysosomal
vesicles. PHA blasts (d14) were fixed and stained for FasL with
NOK1 and Alexa Fluor488-conjugated donkey anti-mouse IgG or for
granzyme A with GrA-11 FITC-conjugated mAbs or for cathepsin B
with polyclonal goat anti-cathepsin B (N-19) antibodies and Alexa
Fluor488-conjugated donkey anti-goat IgG. After extensive washing,
all samples were stained for CD63 with Alexa Fluor555-conjugated
mAb MEM-259. Nuclei were visualized by DAPI (bar: 10 μm).
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densities. As further indicators for the effective organelle
enrichment and separation, we used cytochrome oxidase
subunit IV (CoxIV) as a marker for mitochondria (see
enriched organelles and fraction 5 in Figure 2) and pan-
cadherin as a marker for the plasma membrane (only
present in whole cell lysates). Of note, all proteins that
were enriched in separate fractions were of course also
present in the enriched organelle (EO) fraction placed
on the gradient. However, due to the the relatively low
abundance of individual proteins in the EO fraction,
Western blot detection at the displayed exposure time
did only reveal very faint bands. This is in agreement
with our previous report [11] in which we showed a
massive enrichment of FasL in fraction 2 while in the
starting EO material from different T cell populations,
FasL was almost not detectable at the same exposure
time.
Regarding the “purity” of the obtained fraction, it
should be stressed that most if not all enrichment pro-
tocols published so far do not allow a “purification”
rather than an “enrichment” of a given organelle popula-
tion. This is presumably based on the fact that lysosome
formation and protein loading is a highly dynamic pro-
cess that implies fusion and fission of several membra-
neous compartments and a complex protein sorting and
transport machinery. For the initial characterization of
enriched SL [11], we already pointed to potential “con-
taminations” in fraction 2, using antibodies against
EEA1, a putative marker for endosomes, or Bip/Grp78,
a marker for ER, respectively. Interestingly, during these
analyses, golgin, a marker for the golgi apparatus/cister-
nae was only detected in fractions 3-6, but not in frac-
tions 1 and 2 [11]. For the present study, we thus
restricted ourselves to routinely check for the marker
proteins depicted in Figure 2.
The enriched SL fraction consists of homogeneous intact
vesicles
In addition to the biochemical analysis of the individual
fractions, we visualized the obtained lysosomal fraction
2 by electron microscopy in comparison to the putative
mitochondrial fraction 5. Figure 3 provides characteristic
overview pictures of the two fractions. In both cases, the
organelles within one fraction display a high degree of
homogeneity with respect to their morphology (Figure
3A,C). At higher magnification, the characteristics of the
organelles in fraction 2 become apparent. These mem-
branous vesicles are round-shaped with a maximum size
of about 700 nm and display a characteristic electron
density. In contrast, organelles of fraction 5 are charac-
terized by irregular internal membranous structures
(Figure 3B,D) as expected for mitochondria.
The luminal proteome of enriched SL as analyzed by 2D-
PAGE and mass spectrometry
In order to obtain a comprehensive list of putative lumi-
nal proteins of secretory lysosomes, enriched fraction 2
vesicles of PHA-stimulated T lymphoblasts were sub-
jected to 2D-PAGE. More than 1600 spots from 6 repli-
cate gels were subsequently subjected to proteolytic
Figure 2 Western blot analysis of subcellular fractions.
Individual lanes represent whole cell lysate (WL), enriched
organelles (EO) and the six fractions collected after density gradient
centrifugation of IL-2 expanded T lymphocytes. The blots were
probed with antibodies against respective markers for lysosomal
(CD63, LAMP-1, cathepsin D) and secretory organelles (FasL). Pan-
cadherin served as a marker for plasma membranes, CoxIV for
mitochondria.
Figure 3 Electron micrographs of fractions 2 and 5. Enriched
organelles from PHA blasts corresponding to fractions 2 (A, B) and
5 (C, D) were examined under an electron microscope. Overview
pictures are given in A and C, magnified areas are shown in B and
D. (scale as indicated).
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tion of 1335 spots. Due to repetitive identifications at
respective spot locations in different gels, the actual
number of identified individual spots decreased to 742.
The resulting proteome map is shown as an overview in
Figure 4. Additional information on identified proteins
and images of individual quadrants to match proteins to
respective spots are given as additional files 1, 2 and 3
(Table S1, FigureS1, Dataset S1). Multiple (up to six)
identifications in separate gels from individual secretory
lysosomes preparations from T cells of different donors
also underscore the reproducibility of the isolation pro-
tocol [11]. Overall, the identified spots represent a total
of 397 separate protein entries in the NCBI database
that are listed according to their protein names, the pre-
dicted subcellular distribution and function in Table 1.
Importantly, based on database annotations combining
proteome analyses of different organelles [17], 70% of
the 397 proteins were assigned to lysosomal or secretory
vesicles (including cytolytic granules (CG), lysosomes
(LY), exosomes (EX), endosomes (EN), melanosomes
(ME), platelet granules (PL) and synaptosomes (SY))
(Table 1, Figure 5). The majority of the remaining 30%
was classified as proteins of unknown (11%) or cytosolic
(11%) localization, and as cytosolic or nuclear proteins
(CY/NU, 3.5%). The low percentage of mitochondrial
(MT, 1.5%), nuclear (NU, 0.8%), plasma membrane
(PM, 0.3%) or endoplasmic strictly reticulum-associated
Figure 4 2D proteome map of enriched secretory lysosomes from activated T cell blasts (overview). A total of 250 μgo ff r a c t i o n2
protein were separated on pH 3-11NL IPG strips in the first and on 12.5% Tris-glycin gels in the second dimension. Proteins stained by Flamingo
Pink were detected using fluorescence imaging. From a total of six gels, 742 spots were identified and annotated as 397 individual proteins.
Enlarged sections of all four quadrants are available as additional file to allow the positioning of individual annotations given in table 1.
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Protein name Spot
#
Predicted/annotated subcellular
localisation
Predicted
function
100 kDa coactivator 122 ER,ME,PL biosynthesis
14-3-3 protein beta 714 CY,ME adapter
14-3-3 protein epsilon 685 CY,ME adapter
14-3-3 protein zeta/delta 708 CY,ME adapter
2’,3’-cyclic-nucleotide 3’-phosphodiesterase 542 ME,NG hydrolase
26S protease regulatory subunit 6A 1037 CY,NU protein
degradation
26S proteasome non-ATPase regulatory subunit 2 165 ME proteasome
3-phosphoglycerate dehydrogenase 408 ME biosythesis
acetyl-CoA acetyltransferase, cytosolic 594 CY biosynthesis
ACTB protein 525 ER,ME,EX,PL,SY cell motility
actin related protein 2 isoform b 564 EN,ER,ME trafficking
actin related protein 2/3 complex subunit 1B 590 ME,PL trafficking
actin related protein 2/3 complex subunit 2 674 EN,ME,PL,ER trafficking
actin related protein 2/3 complex subunit 3 799 EN,ME,PL,ER trafficking
actin related protein 2/3 complex subunit 4 798 ER,EX,ME,SY trafficking
actin related protein 2/3 complex subunit 5-like 804 ME trafficking
actin, alpha, cardiac muscle 570 ME cell motility
actin, gamma 1 propeptide 701 ME,EX,PL,SY cell motility
actinin, alpha 4 144 ME,NU,CY cell motility
acylamino acid-releasing enzyme 203 PL, CY hydrolase
acyl-CoA synthetase long-chain family member 4 isoform 2 199 MT,PE,ME metabolism
adenine phosphoribosyltransferase isoform b 784 ME,EX,PL biosynthesis
adenosine deaminase 550 CY,LY hydrolase
adenylosuccinate lyase 439 CY,PL biosynthesis
adenylosuccinate synthetase 1023 CY biosynthesis
adenylyl cyclase-associated protein variant 395 PL,ME trafficking
aflatoxin aldehyde reductase AFAR 1056 PL,GO redox protein
aging-associated gene 12 418 unknown unclassified
alanyl-tRNA synthetase 111 ME,PL biosynthesis
alcohol dehydrogenase class-3 587 PL,CY redox protein
aldo-keto reductase family 1, member A1 1078 PL,SY metabolism
aldolase A 560 EN,ME metabolism
aldose 1-epimerase (BLOCK25) 596 CY metabolism
aldose reductase 981 ME,EX,MT metabolism
alkyldihydroxyacetonephosphate synthase, peroxisomal 273 PE biosynthesis
alpha-tubulin 362 PL cell motility
annexin A1 615 ME,MT trafficking
annexin A11 415 MT,EX,ME trafficking
annexin A2 631 MT,EX,ME,secreted exocytosis
annexin A4 668 MT,EX,ME,SY signal trans.
annexin A5 660 MT,EX,ME,ER trafficking
annexin A6 263 MT,EX,ME,ER trafficking
annexin A7 isoform 2 504 EX,ME,PL exocytosis
ARP3 actin-related protein 3 homolog 465 EN,ER,ME trafficking
ARTS-1 136 ER,ME immunity
aryl hydrocarbon receptor interacting protein 955 unknown unclassified
asparaginyl-tRNA synthetase 306 ME biosynthesis
aspartate aminotransferase 575 CY biosynthesis
ATP citrate lyase 96 ME,EX,PL biosynthesis
ATP synthase, alpha subunit precursor 426 ER,LY,NG,SY,MT channel
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ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2 413 LY,ME,NG,SY channel
axin interactor, dorsalization associated protein 632 unknown signal trans.
beta adrenergic receptor kinase 1 220 CY GTPase
bifunctional purine biosynthesis protein PURH 326 ME,PL mutifunctional
bleomycin hydrolase 463 CY,PL hydrolase
BolA-like protein 2 867 ME unclassified
calcium binding protein 39 622 EX unclassified
CALM3 protein 816 unknown unclassified
calreticulin precursor variant 287 ER,ME,NG,EX,PL,MT chaperone
carboxyl terminal LIM domain protein 612 ER,ME,PL,EN cell motility
catalase 361 PE,ER,LY,EN,ME metabolism
cathepsin B 691 LY,ME,NG hydrolase
cathepsin D preproprotein 696 LY,ME,NG,EX,MT hydrolase
cathepsin H 738 LY hydrolase
cathepsin S 749 LY immunity
Cbr1 In Complex With Hydroxy-Pp 666 ME redox protein
Cdc42ACK GTPASE 790 ME cell motility
centaurin beta1 214 unknown GTPase
chaperonin (HSP60) 338 ME,NG,EX,SY,MT chaperone
chaperonin containing TCP1, subunit 2b 424 ER,EN,ME,PL,MT,CY chaperone
chaperonin containing TCP1, subunit 7h 376 EN,ME,PL chaperone
chaperonin containing TCP1, subunti 5ε 339 EX,PL chaperone
chaperonin containing TCP1, subunti 8τ 357 EN,ME,EX chaperone
chaperonin containing TCP1, subunti 8τ 358 EN,ME,EX chaperone
chromatin modifying protein 4B 639 ME,EX trafficking
chromosome 20 open reading frame 3 (BSCv) 489 ME unclassified
chromosome 9 open reading frame 19 831 EX,GO unclassified
N2 protein 651 unknown unclassified
coactosin-like protein 841 PL,SY unclassified
cofilin 1 810 ER,ME,EX,MT cell motility
copine I 310 ME trafficking
copine III 340 ME,EX,PL trafficking
coronin 7 113 CY,GO trafficking
coronin, actin binding protein, 1A 371 LY,PL cell motility
coronin, actin binding protein, 1C 353 ME multifunctional
c-src tyrosine kinase 475 CY,PL signal trans.
cyclophilin A 826 ME,EX,MT chaperone
cyclophilin B 800 ER,ME chaperone
cystatin B 857 ME protein inhibitor
cysteine and glycine-rich protein 1 769 NU unclassified
cytoskeleton associated protein 952 CY cell motility
cytosolic malate dehydrogenase 642 ME,EX,PL,SY,MT metabolism
DCHT2 Serine/threonine-protein kinase OSR1 332 ME signal trans.
destrin isoform a 814 ME,EX,MT cell motility
differentially expressed in FDCP 6 homolog (mouse), isoform CRA_b 228 unknown unclassified
dihydropyrimidinase-like 2 319 SY signal trans.
dimethylarginine dimethylaminohydrolase 2 683 unknown hydrolase
dipeptidyl peptidase 4 81 ER,LY,EN,ME,EX hydrolase
DJ-1 protein 764 ME,PL,SY,MT redox protein
DnaJ (Hsp40) homolog, subfamily A, member 1, isoform CRA_d 499 ER,ME chaperone
DnaJ (Hsp40) homolog, subfamily B, member 11 precursor 551 ER chaperone
docking protein 2 455 unknown unclassified
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dynamin 2 isoform 1 148 EN trafficking
echinoderm microtubule associated protein like 2 variant 929 CY cell motility
EF-hand domain family, member D2 1012 unknown unclassified
EH-domain containing 1 342 ER,LY,EN,EX,PL trafficking
Ena-VASP-like protein 447 CY cell motility
ENC-1AS aka Beta-hexosaminidase subunit beta 431 LY multifunctional
endoplasmic reticulum protein 29 isoform 1 precursor 721 ER,ME,PL chaperone
enolase 1 variant 496 ME,EX,SY,MT metabolism
ERAP2 protein 99 ER immunity
ERBB2IP protein 197 NU,CY multifunctional
ERO1L 311 ME,ER redox protein
esterase D/formylglutathione hydrolase 656 ME hydrolase
eukaryotic translation elongation factor 1 alpha 1 462 ER,LY,EN,ME,EX,PL biosynthesis
eukaryotic translation elongation factor 1 gamma, isoform CRA_d 947 ME biosynthesis
eukaryotic translation elongation factor 2 158 ER,EN,ME,EX biosynthesis
eukaryotic translation initiation factor 4A 505 ME biosynthesis
eukaryotic translation initiation factor 5A 817 ME biosynthesis
extended-synaptotagmin-1 KIAA0747 protein 155 ME unclassified
ezrin 208 CY cell motility
F-actin capping protein alpha-1 subunit 611 ER,EN,ME actin binding
F-actin capping protein alpha-1 subunit variant 623 ER,EN,ME actin binding
F-actin capping protein alpha-2 subunit 616 ER,EN,ME,PL cell motility
F-actin capping protein beta subunit 663 ER,EN,ME actin binding
farnesyl pyrophosphate synthetase 579 CY biosynthesis
FK506 binding protein 1A 856 ME,SY,MT signal trans.
flotillin 1 486 LY,ME,EX membrane
formin-binding protein 1 1059 SL, LY, CY adapter
fructose-bisphosphate aldolase C 565 ME,SY,MT metabolism
fumarate hydratase, mitochondrial 507 EN,SY,MT cell cycle
FYN-binding protein 71 CY,NU adapter
G protein beta subunit 638 ME,MT signal trans.
galectin-1 851 ME,PL immunity
galectin-3 718 ME,NU immunity
gamma-enolase 476 ME,PL,SY glycolysis
gamma-glutamyl hydrolase 629 LY,ME,NG,PL hydrolase
GDP-mannose pyrophosphorylase A 541 unknown biosythesis
gelsolin-like capping protein isoform 9 572 ME,CY,NU cell motility
GIPC1 protein 598 SY,CY protein binding
glia maturation factor gamma 818 unknown unclassified
glucosamine-6-phosphate deaminase 1 677 CY hydrolase
glucose-6-phosphate dehydrogenase isoform b 409 ME metabolism
glucosidase II subunit beta 126 ER,ME,PL hydrolase
glucosidase, alpha; neutral AB, isoform CRA_a 936 ER,ME,PL hydrolase
glutamate carboxypeptidase 430 unknown hydrolase
glutamate Dehydrogenase-Apo Form 437 ER,ME,PL,MT unclassified
glutaredoxin 3 589 CY redox protein
glutathione S-transferase P1 766 ER,ME,EX,PL metabolism
glutathione synthetase 461 PL redox protein
glutathione-S-transferase kappa 1 765 PL,ME,MT,PE unclassified
glutathione-S-transferase omega 1 698 LY,ME,NG,EX,PL,SY,MT metabolism
glyceraldehyde-3-phosphate dehydrogenase 610 LY,ME,NG,EX,PL,SY,MT metabolism
glycyl-tRNA synthetase 244 ME biosynthesis
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glyoxalase domain containing 4 653 MT unclassified
GNAS complex locus isoform f 531 EX multifunctional
GNB1 protein 634 EN,ME,EX,PL,SY signal trans.
granzyme A 724 SL immunity
GRAP2 protein 957 unknown unclassified
GRB2 protein 756 SY adapter
GTP-binding nuclear protein Ran 755 ME,EX trafficking
guanine nucleotide binding protein (G protein), alpha inhibiting activity
polypeptide 2, isoform CRA_c
582 EX GTPase
guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1, isoform
CRA_d
664 ER signal trans.
guanine nucleotide-binding protein G(k) subunit alpha 585 ME,EX trafficking
guanine nucleotide-binding protein subunit alpha-13 989 ME signal trans.
haloacid dehalogenase-like hydrolase domain containing 2 690 unknown hydrolase
heat shock 70kDa protein 1A 278 ER,EN,ME,EX,MT chaperone
heat shock 70kDa protein 5 226 ER,ME,EX,PL,MT chaperone
heat shock 70kDa protein 8 isoform 1 259 LY,ME,NG,EX,PL,SY,MT chaperone
heat shock 70kDa protein 8 isoform 1 260 LY,ME,NG,EX,PL,SY,MT chaperone
heat shock protein 70 112 EX chaperone
heat shock protein HSP 90-alpha 969 ME,NG,MT chaperone
heat shock protein HSP 90-beta 177 ME,EX,MT chaperone
hematopoietic cell-specific Lyn substrate 1 181 CY,MT signal trans.
HEXA protein 422 LY multifunctional
hexose-6-phosphate dehydrogenase 194 ER metabolism
HIP-55 377 CY signal trans.
histidine triad nucleotide binding protein 1 852 ME,PL,SY hydrolase
histocompatibility (minor) HA-1 1072 unknown GTPase
hypothetical protein 216 unknown unclassified
hypothetical protein LOC79624 472 unknown unclassified
hypoxia up-regulated protein 1 47 ER,PL,ME chaperone
importin subunit beta-1 164 ME trafficking
integrin beta-2 80 PL membrane
interleukin-16 210 secreted immunity
isocitrate dehydrogenase 1 (NADP+), soluble, isoform CRA_b 540 ME,EX,PL redox protein
isocitrate dehydrogenase 2 (NADP+), mitochondrial, isoform CRA_b 510 PL,MT redox protein
kinase/transmembrane domain fusion protein 1061 unknown unclassified
laminin-binding protein 543 ME,ER cell adhesion
leucine aminopeptidase 3 432 CY protein
degradation
leucine rich repeat containing 57 747 unknown unclassified
leucine-rich repeat and calponin homology domain-containing protein 5 908 MT protein binding
leucocyte antigen CD97 872 ME,secreted cell adhesion
leukocyte-derived arginine aminopeptidase long form variant 102 unknown hydrolase
leukotriene A4 hydrolase 309 CY hydrolase
LIM and SH3 domain protein 1 606 ER,EN,ME,PL adapter
LIM domain-containing protein 2 834 unknown unclassified
lin 7 homolog c 1070 SY exocytosis
L-lactate dehydrogenase 645 ME,EX,SY metabolism
L-lactate dehydrogenase B chain 626 ME,EX,PL,SY,MT redox protein
L-plastin 266 CY actin binding
L-plastin variant 267 unknown cell motility
LPXN protein 474 unknown unclassified
lymphocyte cytosolic protein 2 229 CY immunity
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lymphocyte-specific protein 1 959 PL immunity
lysosomal acid alpha-mannosidase 265 LY,ME hydrolase
M2-type pyruvate kinase 356 ME,EX,SY metabolism
Macrophage Migration Inhibitory Factor (Mif) With Hydroxphenylpyruvate 862 ME,EX,PL,SY immunity
MAGUK p55 subfamily member 7 292 PL protein binding
methylenetetrahydrofolate dehydrogenase 1 139 EN,ME,PL,MT multifunctional
methylthioadenosine phosphorylase 697 CY metabolism
MHC class I antigen 533 ME immunity
MHC class I antigen 865 ME immunity
MHC class II antigen 953 ME immunity
MHC class II antigen DR alpha chain 1050 LY immunity
MHC class II antigen DR52 1083 ME immunity
microtubule-associated protein, RP/EB family, member 1 665 ME,PL cell motility
mitochondrial ATP synthase, H+ transporting F1 complex beta subunit 443 MT trafficking
mitochondrial trifunctional protein, alpha subunit precursor 253 PL, MT metabolism
mitogen-activated protein kinase 1 569 ME,PL signal trans.
mitogen-activated protein kinase kinase 1 interacting protein 1 943 LY adapter
mitogen-activated protein kinase kinase 2 509 unknown signal trans.
moesin, isoform CRA_b 246 EN,ME,EX,PL,MT cell motility
mps one binder kinase activator-like 1B 758 unknown unclassified
myosin IG 75 unknown trafficking
myosin light polypeptide 6 830 ME cell motility
NADH dehydrogenase (ubiquinone) Fe-S protein 1, 75 kDa (NADH-coenzyme Q
reductase)
896 ER,ME,MT trafficking
NCK adaptor protein 1 506 CY,ER adapter
NECAP endocytosis associated 2 1010 EN trafficking
NESH protein 434 unknown unclassified
N-ethylmaleimide-sensitive factor attachment protein, alpha 652 ME,NG,PL trafficking
neuroblastoma RAS viral (v-ras) oncogene homolog 779 GO,CY trafficking
neuropolypeptide h3 781 ME,EX,SY protein inhibitor
neutrophil adherence receptor alpha-M subunit 36 membrane cell adhesion
niban protein isoform 2 38 CY signal trans.
NME1-NME2 protein 823 CY,NU multifunctional
nuclear chloride channel 684 ME,EX,PL,MT channel
nucleobindin 1 variant 335 unknown unclassified
nucleoside phosphorylase 670 CY,PL cell cycle
nucleosome assembly protein 1-like 1, isoform CRA_d 315 ME,PL,NU cell cycle
Obg-like ATPase 1 511 EN,ME,PL hydrolase
otubain 1 637 ME hydrolase
PA2G4 protein 490 unknown unclassified
PDCD6IP protein 171 unknown unclassified
perforin-1 280 SL immunity
peroxiredoxin 1 774 ER,LY,EN,ME,NG,PL,MT redox protein
peroxiredoxin 2 778 ER,EN,ME,SY,MT redox protein
peroxiredoxin 3 768 ME,PL,MT redox protein
peroxiredoxin 4 737 ER,EN,ME redox protein
peroxiredoxin 6 945 LY,ME,EX,PL,SY redox protein
PGAM1 730 ME,EX,SY metabolism
PHB 948 unknown unclassified
phosphatase 2a 316 MT multifunctional
phosphatidylinositol-5-phosphate 4-kinase, type II, alpha 457 NG,PL metabolism
phosphofructokinase, liver 939 unknown glycolysis
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phosphofructokinase, platelet 196 ME,PL glycolysis
phosphoglucose isomerase 390 ME,EX,PL,MT multifunctional
phosphoglycerate kinase 1 537 ME,EX,SY,MT metabolism
phospholipase C, delta 1 variant 178 unknown signal trans.
phosphoribosyl pyrophosphate synthetase 1 variant 1080 unknown biosynthesis
phosphoribosylaminoimidazole carboxylase, - succinocarboxamide synthetase,
isoform CRA_b
523 EN,SY multifunctional
phosphoribosylformylglycinamidine synthase 64 CY biosynthesis
phosphoserine aminotransferase 1 988 ME biosynthesis
phostensin 91 CY unclassified
poly(A) binding protein, cytoplasmic 1, isoform CRA_c 256 ER,EN,ME,PL metabolism
poly(rC) binding protein 1 1082 ME,CY,NU unclassified
potassium voltage-gated channel, shaker-related subfamily, beta member 2 isoform
2
635 CY channel
PPP5C protein 364 CY,NU hydrolase
profilin-1 848 ME,EX,PL,MT actin binding
programmed cell death protein 10 741 unknown apoptosis
proline synthetase co-transcribed homolog 699 CY unclassified
prolyl 4-hydroxylase, alpha subunit 337 ER,ME redox protein
prolyl 4-hydroxylase, beta subunit precursor 348 ER,ME,EX,PL,MT redox protein
prolyl endopeptidase 234 CY protein
degradation
proteasome (prosome, macropain) subunit, alpha type, 7(PSMA7) 729 CY,Proteasom hydrolase
proteasome 26S non-ATPase subunit 13 isoform 1 577 ME proteasome
proteasome 26S subunit, ATPase, 2 498 CY,NU unclassified
proteasome 26S subunit, ATPase, 5 514 CY,NU unclassified
proteasome activator complex subunit 1 isoform 1 703 PL,MT immunity
proteasome activator complex subunit 2 689 ME immunity
proteasome alpha 2 subunit variant 754 CY hydrolase
proteasome subunit, alpha type, 1 687 ME hydrolase
proteasome subunit, alpha type, 5 1009 ME hydrolase
proteasome subunit, alpha type, 6 734 CY,NU hydrolase
proteasome subunit, beta type, 1 750 ME,CY hydrolase
proteasome subunit, beta type, 2 780 CY,NU hydrolase
proteasome subunit, beta type, 4 944 CY,NU hydrolase
proteasome subunit, beta type, 8 773 PL,CY,NU immunity
protein ARMET 805 ME, secreted unclassified
protein diaphanous homolog 1 45 ME cell motility
protein disulfide isomerase-associated 4 1060 ER,ME,PL chaperone
protein disulfide isomerase-related protein 5 458 ER,ME chaperone
protein disulfide-isomerase A3 379 ER,LY,ME,NG,EX,PL chaperone
protein phosphatase 1, catalytic subunit, alpha isoform 1 603 EX hydrolase
protein phosphatase 1, catalytic subunit, beta isoform 617 ME,PL hydrolase
protein tyrosine phosphatase 1b 536 ME,ER hydrolase
protein tyrosine phosphatase, non-receptor type 6 isoform 1 variant 317 unknown hydrolase
protein-tyrosine kinase fyn isoform c 373 EN,CY signal trans.
PYD and CARD domain containing 771 CY apoptosis
pyrophosphatase 1 654 ME,MT hydrolase
pyruvate kinase 3 isoform 2 346 ME,EX,SY metabolism
R33729_1 (Interleukin-25) 837 ME,secreted signal trans.
Rab GDP dissociation inhibitor beta 469 ME,EX,PL,MT GTPase
raftlin cell migration-inducing gene 2 193 PL unclassified
Rap1a 785 EN,ME,MT GTPase
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Rap1-GTP-interacting adapter molecule 141 CY signal trans.
Ras GTPase-activating-like protein IQGAP2 1069a EN signal trans.
related RAS viral (r-ras) oncogene homolog 2 isoform a 1049 LY,ME,EX GTPase
Rho GDP dissociation inhibitor (GDI) alpha 716 ME,PL,MT GTPase
Rho GDP dissociation inhibitor (GDI) beta 728 CY GTPase
Rho GTPase activating protein 1 441 PL GTPase
Rho GTPase-activating protein 9 998 unknown GTPase
ribosomal protein L11 797 ribosome biosynthesis
ribosomal protein L12 809 EN,ribosom biosynthesis
S-adenosylhomocysteine hydrolase 513 ME hydrolase
Sec23 homolog A 221 ER,ME,PL trafficking
Sec23B protein 1001 EN trafficking
septin 2 554 ME,EX,SY unclassified
septin 7 484 ME,PL,SY unclassified
septin-9 delta 558 ME unclassified
septin-9 gamma 973 ME unclassified
serine/threonine phosphatase 1 gamma 985 MT,SY hydrolase
serine/threonine-protein kinase PAK 2 352 PL signal trans.
serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform 621 MT signal trans.
serine/threonine-protein phosphatase 2A regulatory subunit B 592 NU signal trans.
serpin peptidase inhibitor,clade B,member 1 548 CY protein inhibitor
seryl-tRNA synthetase 365 ME,PL tRNA
processing
SH2 domain protein 1A 840 CY signal trans.
SH3-containing protein, Endophilin-B1 1081 CY,GO,MT apoptosis
SHUJUN-1 795 CY cell motility
signal transducer and activator of transcription 1, 91kDa, isoform CRA_d 188 CY,NU signal trans.
similar to metallo-beta-lactamase superfamily protein 686 unknown hydrolase
small GTP binding protein Rac2, isoform CRA_c 1006 unknown signal trans.
soc-2 suppressor of clear homolog 318 CY unclassified
solute carrier family 9 (sodium/hydrogen exchanger), isoform 3 regulator 1 460 ME,EX,PL scaffolding
sorting nexin 17 421 EN,ME,PL trafficking
sorting nexin 6 466 CY trafficking
src kinase associated phosphoprotein 1 isoform 1 417 CY,NU signal trans.
stathmin 1/oncoprotein 18 820 SY cell motility
stress-induced-phosphoprotein 1 (Hsp70/Hsp90-organizing protein) 323a ME,PL,SY chaperone
stromal cell-derived factor 2-like 1 precursor 767 ER unclassified
superoxide dismutase 1, soluble 806 ME,EX,MT redox protein
syntaxin binding protein 1 305 ME,NG,EX,PL,SY trafficking
syntaxin binding protein 2 302 EX,PL trafficking
syntaxin binding protein 3 variant 294 ME,PL trafficking
talin-1 920 EN,ME,PL cell motility
tapasin isoform 3 precursor 495 ER,ME immunity
TC4 protein 736 NU GTPase
T-complex polypeptide 1 1030 ER,EN,ME,EX chaperone
T-complex protein 1 subunit gamma 307 CY chaperone
testin isoform 1 456 unknown unclassified
thioredoxin domain-containing protein 4 precursor 502 ER,ME,PL scaffolding
transfer RNA-Trp synthetase 411 ME,PL biosynthesis
transgelin-2 787 ME,MT unclassified
transketolase 276 ME,EN unclassified
translocon-associated protein subunit delta 811 ME,ER trafficking
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triosephosphate isomerase 1 742 ME,EX,SY,MT unclassified
tripeptidyl-peptidase 1 992 LY,ME,NG,PL,MT protein
degradation
tropomodulin 3 561 ER,ME cell motility
tropomyosin 3 isoform 2 676 unknown unclassified
tropomyosin 4 672 ME unclassified
Tu translation elongation factor, mitochondrial 517 LY,ME,PL,MT biosynthesis
tubulin alpha 6 variant 363 ME,PL cell motility
tubulin tyrosine ligase-like family, member 12 897 ME trafficking
tubulin, beta 407 ME,PL,SY cell motility
tubulin, beta polypeptide 433 ME,PL,SY cell motility
tumor rejection antigen (gp96) 1 118 ER,ME,PL,GO chaperone
tumor susceptibility gene 101 470 EX trafficking
twinfilin-like protein 578 CY cell motility
tyrosine kinase LCK 399 CY signal trans.
tyrosine-protein phosphatase non-receptor type 6 325 CY,NU signal trans.
tyrosyl-tRNA synthetase 366 ME,PL signal trans.
ubiquitin associated and SH3 domain containing protein A 913 CY,NU protein
degradation
ubiquitin specific peptidase 5 isoform 2 154 LY,ME,NG protein
degradation
ubiquitin specific protease 14 isoform a 344 PL protein
degradation
ubiquitin-conjugating enzyme E2 L3 882 MT protein
degradation
ubiquitin-conjugating enzyme E2 N 839 ME,EX,MT differentiation
ubiquitin-like modifier-activating enzyme 1 120 MT,ME protein
degradation
UDP-glucose ceramide glucosyltransferase-like 1 isoform 1 39 ER,ME chaperone
UDP-glucose pyrophosphorylase 2 isoform b 442 EN,ME metabolism
UNC-112 related protein 2 long form 971 PL cell adhesion
unnamed protein product 706 unknown unclassified
UPF0550 protein C7orf28 450 ME unclassified
vacuolar H+-ATPase 56,000 subunit 414 LY,ME,NG,SY channel
vacuolar protein sorting 45A 322 LY,EN trafficking
vacuolar sorting protein 33A 1067 EN,LY trafficking
valosin-containing protein 159 unknown unclassified
vasodilator-stimulated phosphoprotein 503 PL cell motility
vinculin 108 ME cell motility
voltage-dependent anion channel 1 658 ER,LY,ME,NG,EX,PL,SY,MT channel
voltage-dependent anion channel 2 657 SY,MT channel
voltage-dependent anion channel 3 688 EN,ME,MT channel
V-type proton ATPase subunit d 1 599 LY,EN,ME,SY channel
WD repeat domain 1 304 EN,ME,EX cell motility
Wiskott-Aldrich syndrome protein 323b CY cell motility
XRP2 protein 546 ME signal trans.
zeta-chain associated protein kinase 70kDa 277 CY signal trans.
397 individual proteins were identified to be associated with enriched secretory lysosomes from human T cell blasts. The proteins are listed by name, followed
by individual spot numbers and the predicted/annotated subcellular localisation and function. Abbreviations: LY: lysosomes, ME: melanosomes, PL: platelet
granules, SY: synaptosomes, EX: exosomes, CG: cytotoxic granules, NG: neuromelanin granules, EN: endosomes, MT: mitochondria, GO: Golgi, PE: peroxisomes,
CY: cytoplasm, ER: endoplasmic reticulum and NU: nucleus. For detailed information on individual spots/proteins, please refer to the additional files.
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Page 12 of 16(ER, 1.5%) and peroxisomal proteins (PE, 0.3%) again
underscores the selective enrichment of lysosomal orga-
nelles in the present study. In terms of function, the
classification revealed a large heterogeneity and a broad
spectrum of potential activities. However, as expected,
proteins associated with degradation, signal transduc-
tion, trafficking and immunity formed about 35% of the
total proteome of enriched SL (Figure 5B). The impor-
tant role of these organelles in cytotoxicity is also
supported by the identified effector molecules perforin
(#280) and granzyme A (#707, 717, 720, 724).
Interestingly, and in contrast to the published SL pro-
teome of NK cells [12], we did not detect significant
amounts of granzyme B at the respective position in 2D
gels from T cell blasts. However, this is in line with our
previous observation that granzyme B might be stored
in a separate compartment formed by electron dense
granules that do not contain transmembrane FasL and
Figure 5 Classification of the identified proteins according to their localization (A) and function (B). The cellular localization and function
of 397 identified proteins were classified as detailed in material and methods. Lysosomal and secretory vesicles are represented by
melanosomes (ME), lysosomes (LY), platelet granules (PL), endosomes (EN), synaptosomes (SY), exosomes (EX) or cytolytic granules (CG). Other
cellular compartments are: cytosol (CY), nuclei (NU), peroxisomes (PE), plasma membrane (PM), mitochondria (MT), golgi (GO) or endoplasmic
reticulum (ER).
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Page 13 of 16that sediment as fraction 6 in our enrichment gradient
[11]. To prove this result and address this issue in more
detail, we started to analyze fraction 2 and fraction 6
vesicles (granzyme B granules). The direct comparison
of the two granule populations by 2D DIGE and Wes-
tern blotting clearly verified the result of the present
analysis and provided first biochemical and proteomic
evidence for two distinct species of cytotoxic effector
vesicles in T cell blasts [18].
Surprisingly, it is still unknown to date whether func-
tionally distinct TCRab and TCRgδ Tc e l l s ,C D 4
+ and
CD8
+ Tc e l l s ,v δ1
+ and vδ2
+ T cells, or normal and leu-
kemic T cells also differ in terms of protein content and
function of their lysosomal compartment(s). Based on
the present description of the luminal proteome of
FasL-containing secretory lysosomes in fully differen-
tiated T cells, it will be possible to directly compare the
content of cytotoxic effector organelles in different
T cell subpopulations, e.g. by 2D difference gel electro-
phoresis. In addition, based on a larger set of marker
proteins, the maturation of effector vesicles in the
course of T cell activation can now be addressed in
detail. Of note, using the applied protocol, we identified
the luminal rather than the membrane proteome of this
vesicular population. In addition, one has to consider
that due to methodological limitations, the applied 2D
technique might cover only about 20-30% of the total
proteome and thus might be complemented in future
studies employing LC-coupled mass spectrometric
approaches.
Conclusion
We provide the first comprehensive proteome map of
T cell-derived secretory lysosomes with only minor con-
taminations by cytosolic, nuclear or other proteins. This
information will be useful to more precisely address the
activation-dependent maturation and the specific distri-
bution of effector organelles and proteins in individual
T or NK cell populations in future studies.
Methods
Cells
Human peripheral blood mononuclear cells (PBMC)
were isolated from buffy coat preparations by Ficoll
density gradient centrifugation. For the generation of
PHA-stimulated lymphoblasts, T cells were purified by
magnetic cell sorting (MACS) using cell isolation kits
from Miltenyi Biotech (Bergisch Gladbach, Germany).
The cells were stimulated with phytohemagglutinin
A( P H A ,0 . 5μg/ml, Remel, Lenexa, KS, USA) and
expanded in the presence of irradiated EBV-transformed
B cells and allogenic PBMC and subsequently with
recombinant interleukin 2 (rIL-2, 100 U/ml, Chiron
GmbH, Marburg, Germany). Before the cells were
analyzed on day 12-14, dead cells were removed by
Ficoll-gradient centrifugation resulting in a > 98% pure
T cell population as judged by CD3 FACS analysis.
Confocal microscopy
Cells were fixed with 3% paraformaldehyde and permea-
bilized with 1% Triton X-100 as described [13]. The
following antibodies were used: mouse IgG1 isotype-
control MOPC-21 (Abcam, Ca m b r i d g e ,U K ) ,a n t i - F a s L
mAb NOK1 (BD Biosciences, Heidelberg, Germany)
with AlexaFluor488-conjugated goat anti-mouse IgG
(Invitrogen, Karlsruhe, Germany), anti-CD63 mAb clone
MEM-259 (Immunotools, Friesoythe, Germany) conju-
gated to AlexaFluor555 (Invitrogen), anti-Granzyme
A-FITC (Immunotools) and anti-Cathepsin B (Santa
Cruz Biotechnology, Santa Cruz, CA, USA) with Alexa-
Fluor488-conjugated donkey anti-goat IgG (Invitrogen).
Stained samples were mounted with ProLong Gold anti-
fade reagent with DAPI (Invitrogen) and analyzed on a
laser scanning microscope (LSM 510 Meta, Carl Zeiss,
Jena, Germany) with appropriate filter settings. Images
were acquired via scanning through the x-y-plane with
63 × objective lense. Laser intensity and detectors were
adjusted to a uniformly negative signal of the control
samples stained with control IgG and second step
antibodies.
Subcellular fractionation
For subcellular fractionation and enrichment of secre-
tory lysosomes, at least 4x10
8 T cells were used. The
fractionation procedure has been recently described in
detail [11]. Briefly, the cells were mechanically disrupted
and organelles were enriched by differential centrifuga-
tion steps. The enriched organelles were then loaded on
a discontinuous density gradient (4.4 ml volume) with
27%, 22.5%, 19%, 16%, 12%, 8% Optiprep
® which is a
60% Iodixanol solution (Sigma, Deisenhofen, Germany)
and subjected to ultracentrifugation. Interphases were
collected from the top of the gradient resulting in six
400 μl fractions named and numbered 1 to 6. The pro-
tein content in each fraction was determined using a
Coomassie Protein Assay Reagent (Thermo, Rockford,
IL, USA).
Western blot analysis
For Western blotting, 5 μg of protein were separated by
SDS-PAGE on pre-casted 4-12% gradient Bis-Tris gels
(Invitrogen). After transfer to nitrocellulose (NC) mem-
branes (Biometra, Goettingen, Germany) and blocking
with 5% BSA or dry milk, the fractions were analyzed
for subcellular marker proteins with the following
antibodies: anti-FasL clone G-247.4 (BD Biosciences),
anti-CD63 clone MEM-259 (Acris Antibodies, Herford,
Germany), anti-LAMP-1 clone 25 (BD Biosciences),
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chrome oxidase IV (CoxIV) mAb clone 10G8D12C12
(1/1000, MitoScience, Eugene, OR, USA), anti pan-cad-
herin clone ab22744 (Abcam, Cambridge, UK) and
horseradish peroxidase (HRP)-conjugated goat anti-
mouse secondary antibody (GE Healthcare, Munich,
Germany). Membranes were prepared for reprobing by
incubation in stripping solution (100 mM 2-mercap-
toethanol, 2% SDS, 60 mM Tris) for 25 min at 56°C.
ECL reagents in combination with Hyper Film (GE
Healthcare) were used for chemiluminescence detection.
Transmission electron microscopy
Enriched organelles of fractions 2 and 5 were fixed with
a mixture of 3% paraformaldehyde and 0.05% glutaralde-
hyde in PBS at 4°C overnight, washed in PBS, postfixed
in 2% OsO4, dehydrated in ethanol, and embedded in
araldite (Sigma, Deisenhofen, Germany). Ultrathin sec-
tions were mounted on formvar-coated grids and dou-
ble-stained with a saturated solution of uranyl acetate in
70% methanol and lead citrate. The grids were examined
with a Zeiss EM 900 transmission electron microscope
equipped with a digital camera system.
2D electrophoresis, image analysis and spot picking
The 2D electrophoresis was performed as described
before [11]. Briefly, SL pellets of fraction 2 were lysed
on ice for 30 min with 30 μl lysis buffer (pH 8.5) con-
taining 7 M urea, 2 M thiourea, 30 mM Tris, 4%
CHAPS. The supernatant was recovered after centrifu-
gation for 20 min at 20.000 × g at 4°C. A total amount
of 250 μg of protein was mixed with rehydration buffer
(7 M urea, 2 M thiourea, 4% CHAPS, 2% (v/v), IPG buf-
fer pH 3-11 and 2% (w/v) DTT) and applied by cup-
loading onto 24 cm non-linear pH 3-11 IPG gel strips
for isoelectric focusing (IEF). The second dimension was
performed on 26 × 20 cm large 12.5% polyacrylamide
gels after reduction and alkylation using the Ettan
DALTsix large vertical electrophoresis system from GE
Healthcare. The gels were removed from the glass
plates, stained with Flamingo Pink (Bio Rad), mounted
on a non-backed gel frame, scanned on a Typhoon Trio
imager (GE Healthcare) and analyzed using Image Mas-
ter 6.0 (GE Healthcare). Selected spots were picked with
a 2 mm picking head. The picked gels were again
scanned to verify the correct location of the punched
spots.
In-gel tryptic digestion and mass spectrometry
Gel plugs were washed with water and 12.5 mM ammo-
nium bicarbonate (ABC) in 50% acetonitrile (ACN) and
dehydrated in pure ACN. The dry gel pieces were rehy-
drated with 100 ng sequencing-grade trypsin (Serva,
Heidelberg, Germany) in 5 mM ABC and tryptic in-gel
digestion was performed at 37°C overnight. For peptide
extraction, 0.3% trifluoroacetic acid (TFA) in ACN was
added and the samples were sonicated for 15 min. The
liquid phases were collected, lyophilized, redissolved in
0.5 to 1 μl MALDI matrix solution (3.2 mg/ml a-cyano-
hydroxycinnamic acid (Sigma) in 65% ACN/0.1% TFA),
spotted onto 192-well stainless steel MALDI plates and
air-dried. The samples were analyzed by peptide mass
finger printing in positive reflectron mode followed by
MSMS analyses of the most apparent five peptides using
the 4700 Proteomics Analyzer mass spectrometer
(Applied Biosystems, Framingham, MA, USA) as
described elsewhere [12]. Peptide mass spectra were
processed by internal calibration with autolytic frag-
ments of porcine trypsin with 25 ppm mass tolerance.
MSMS spectra were acquired using default calibration
updated prior to the run. Spectral data were searched
against human proteins in the NCBI database (Homo
sapiens, 192,176 entries) using MASCOT V2.0 (Matrix
Sciences, London, UK).
Database analysis
Database searches with MASCOT were performed using
the following parameters: the modification on cysteine
residues by carbamidomethylation was set as obligate,
methionine oxidation was considered as a potential
modification; the maximum number of missed tryptic
cleavages was one; the monoisotopic masses were con-
sidered and the mass tolerance was set to ± 50 ppm,
and the fragment-ion mass tolerance was set to 0.2 Da
(MS/MS). A protein was accepted to be identified when
the total protein score reached or exceeded the
MASCOT score threshold (≥ 65 with a probability of
identification greater 95%). A repeated search against a
randomized decoy database (http://www.matrixscience.
com/help/decoy_help.html) using the decoy.pl script and
identical search parameters let to a false-positive rate of
1.2%.
The classification according the localization and func-
tion of individual proteins was based on the Uni-Prot
knowledge base, the iHOP database [19] and the
iProXpress database [17] available through the Protein
Information Resource (PIR) (GUMC, Washington DC,
USA). Identified proteins were searched in this
organelle-proteome reference dataset according to their
Uni-Prot numbers.
Additional material
Additional file 1: Table S1. List of identified spots in enriched SL
preparations from activated T cells. 742 spots representing 397
proteins were identified and annotated according to Figure S1 A-D.
Proteins (3) are listed with spot numbers (1), the number of iterant
identifications (2), respective NCBI accession (4) and Uni-Prot (5)
numbers, theoretical molecular weights (MW) (6) and isoelectric points
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Page 15 of 16(pI) (7). In addition, the total MASCOT score (8), matched (9) and
unmatched (10) peptides and the sequence coverage (11) are given. The
protein function (12), and the subcellular localization (13) of the
respective protein are assigned according to PIR, Uni-Prot and iHOP
databases. Abbreviations: LY: lysosomes, ME: melanosomes, PL: platelet
granules, SL: secretory lysosomes, NG: neuromelanin granules, SY:
synaptosomes, EX: exosomes, EN: endosomes, MT: mitochondria, GO:
Golgi, PE: peroxisomes, CY: cytoplasm, ER: endoplasmic reticulum and
NU: nucleus.
Additional file 2: Figure S1. Proteome map of enriched secretory
lysosomes from T cells. The 742 annotated spots are displayed in four
separately enlarged quadrants (A-D) of one representative of the six
performed 2D gels. Identifications are combined based on six repetitive
experiments.
Additional file 3: Dataset S1. Protein identification data. Protein
identification data are displayed as MASCOT’s “Protein View” including
matched peptides, sequence coverage and ion scores (for MS/MS
identifications). Please use bookmarks for navigation.
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